SolGent Co., Ltd. is a South Korea-based company specializing in genetic technology solutions. Founded in 2000, the company has experienced significant growth over the past decade, leveraging strong relationships with valued customers and a reputation for producing high-quality products. SolGent initially focused on manufacturing essential raw materials for molecular biology, including DNA polymerase, before expanding its offerings to include a range of molecular diagnostic kits in 2012. The company's products are distributed globally and are utilized by prominent organizations such as the KCDC (Korea Centre for Disease Control) and Korea's National Institutions and Hospitals. Operating from a well-established manufacturing center and research institute spanning 2,000sqm in Daejeon, South Korea, SolGent ensures that all its products, including molecular diagnostic kits, adhere to strict quality standards, holding certifications such as ISO9001:2008 and ISO13485:2003. Moreover, several diagnostic kits have obtained CE-IVD certification, with additional products undergoing certification processes. The company's business areas include molecular diagnostics, research reagents, and sequencing analysis, with a commitment to quality evident through its 100% QD Double check system for all products. SolGent's dedication to quality and innovation has been acknowledged through achievements and rewards such as ISO9001:2008, ISO13485:2003, and CE certification for molecular diagnostics. This South Korean company continues to make an impact in the health care and manufacturing industries, showcasing its capabilities and commitment to excellence in genetic technologies. For more information about SolGent and its products, interested parties can visit the company's website at www.solgent.com or solgent.tradekorea.com.
There is no investment information
No recent news or press coverage available for SolGent Co., Ltd..